Hinge Health (HNGE) Return on Capital Employed (2025 - 2026)

Hinge Health's (HNGE) quarterly Return on Capital Employed came in at 163.65% in Q1 2026, down 18.28% quarter-over-quarter from 138.37% in Q4 2025.

Hinge Health (HNGE) Return on Capital Employed (2025 - 2026) Analysis & Trends

Hinge Health has disclosed Return on Capital Employed across 2 years of filings, most recently posting 163.65% for Q1 2026.

Return on Capital Employed for Q1 2026 came in at 163.65%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 163.65% (changed N/A YoY), and the FY2025 annual result was 157.64%, changed N/A from the prior year.
Return on Capital Employed came in at 163.65% for Q1 2026 at Hinge Health, down from 138.37% in the prior quarter.
In the past five years, Return on Capital Employed ranged from a high of 138.37% in Q4 2025 to a low of 163.65% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	13.00%
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	2.09%
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	10.67%
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-163.65%
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-4.23%
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	21.81%
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	4.73%
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	4.60%
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	2.23%
10	Teladoc Health	1.45 Bn	696.57 Mn	562.57 Mn	-8.41%

Download Data